Even Healthcare Tests Fixed Salaries in Its Own Hospitals

Even Healthcare's premise is that hospital revenue should track health outcomes rather than procedure volume. TechCrunch reports the Indian startup raised a $50 million Series B led by Khosla Ventures at a $300 million valuation and now builds and runs its own hospitals. The open question is whether that structure delivers durable economics. The same report documents a wider net loss and a large restructuring, so the model is promising but not yet proven.

What the funding actually buys

According to TechCrunch's reporting, the all-equity round included Alpha Wave and brings total capital raised above $120 million. Even says it will use the money to open five more hospitals in Bengaluru over six months. Co-founder Mayank Banerjee told the publisher that Even leases buildings on 20-year agreements and funds fit-out and medical equipment itself. This is capital-intensive vertical integration rather than a software layer, and the disclosed plans are expansion commitments, not independently verified financial outcomes.

The incentive design under scrutiny

The reported mechanism is compensation structure. Banerjee said doctors receive fixed salaries, not pay tied to test or surgery counts, though bonuses can follow patient-reported clinical outcomes. Management pay is likewise not linked to procedure volume, and every employee receives equity. Vinod Khosla, in a prepared statement cited by TechCrunch, said the aim is to reward better health outcomes rather than greater use of healthcare services. The logic is coherent, but the article documents the design, not a controlled test showing that fixed salaries cause better outcomes.

Which results are verified and which are claimed

TechCrunch attributes to Banerjee that both Bengaluru hospitals reached operational profitability, excluding depreciation, within a year. Even claims an unplanned readmission rate under 1% against an 8% to 15% industry benchmark, 40% shorter stays, and more than ₹500 million saved for insurers. These figures come from the company, with comparison data on its own website; the article does not show independent audit. Regulatory filings cited by TechCrunch do show a net loss of about ₹902 million in fiscal 2025 on revenue of about ₹272 million.

Scale and the cost of growth

The reported scale is about 250,000 members and more than 750,000 patient interactions since 2021, with roughly 650 employees including about 300 full-time doctors. TechCrunch also reports, citing Entrackr, that Even laid off about 350 people in August; Banerjee acknowledged the restructuring and described severance, extended health insurance and accelerated equity vesting. He said profitability could come within months if expansion spending stopped, but declined to give a date. That statement is a founder's assertion, and the reported layoffs sit awkwardly beside rapid hospital expansion.

What would count as real validation

Our editorial inference is that the decisive test is not occupancy but whether outcome-linked contracts with insurers become recurring revenue. Banerjee said Even is working with insurer partners on a model that could compensate it for hospitalizations it helps prevent; that is described as in progress, not completed. Independent clinical and cost audits across multiple hospitals would strengthen the case. Until then, the reported operational profitability and the reported net loss both belong in the same picture. For related reading on technology in care delivery, see this internal article and this analysis. A separate Wired report on supplement claims is unrelated to Even but illustrates how carefully health promises should be read.